About Our Board Members

Caliber Biotherapeutics has a strategic alignment with the Mary Crowley Cancer Research Center in Dallas Texas for rapid development and entry into clinical phase investigations for therapeutic proteins and vaccines products in the cancer therapies.

The mission of Mary Crowley Cancer Research Centers is to expand treatment options for all cancer patients through investigational vaccine, gene and cellular therapies. With the Caliber/ Crowley Center alignment novel cancer therapies products can be developed and moved into a clinical setting at a very rapid and efficient pace.